Literature DB >> 30320583

An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1.

Velmarini Vasquez1,2,3,4, Joy Mitra1,4, George Perry5, K S Rao2, Muralidhar L Hegde1,4,6.   

Abstract

Altered expression of α-synuclein is linked to Parkinson's disease (PD). A major challenge to explore how the increased α-synuclein affect neurotoxicity is the lack of a suitable human neuronal cell model that mimics this scenario. Its expression in neural precursors affects their differentiation process, in addition to the neuronal adaptability and variability in maintaining a constant level of expression across passages. Here, we describe an SH-SY5Y line harboring Tet-ON SNCA cDNA cassette that allows for induction of controlled α-synuclein expression after neuronal differentiation, which can be an important tool for PD research.

Entities:  

Keywords:  Parkinson’s disease; dopaminergic neurons; inducible α-synuclein expressing neuronal model for PD; α-synuclein

Mesh:

Substances:

Year:  2018        PMID: 30320583      PMCID: PMC6221916          DOI: 10.3233/JAD-180610

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  26 in total

1.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells.

Authors:  He-Jin Lee; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

3.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

4.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.

Authors:  Velmarini Vasquez; Joy Mitra; Pavana M Hegde; Arvind Pandey; Shiladitya Sengupta; Sankar Mitra; K S Rao; Muralidhar L Hegde
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 6.  α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.

Authors:  Naomi P Visanji; Jonathan M Brotchie; Lorraine V Kalia; James B Koprich; Anurag Tandon; Joel C Watts; Anthony E Lang
Journal:  Trends Neurosci       Date:  2016-10-21       Impact factor: 13.837

7.  Genetic screens in human cells using the CRISPR-Cas9 system.

Authors:  Tim Wang; Jenny J Wei; David M Sabatini; Eric S Lander
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

8.  Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation.

Authors:  Bernard L Schneider; Corey R Seehus; Elizabeth E Capowski; Patrick Aebischer; Su-Chun Zhang; Clive N Svendsen
Journal:  Hum Mol Genet       Date:  2007-02-19       Impact factor: 6.150

9.  Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Methods Mol Biol       Date:  2013

Review 10.  Alpha-synuclein biology in Lewy body diseases.

Authors:  Woojin Scott Kim; Katarina Kågedal; Glenda M Halliday
Journal:  Alzheimers Res Ther       Date:  2014-10-27       Impact factor: 6.982

View more
  4 in total

1.  Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis.

Authors:  Erika N Guerrero; Joy Mitra; Haibo Wang; Suganya Rangaswamy; Pavana M Hegde; Priyadarshini Basu; K S Rao; Muralidhar L Hegde
Journal:  Hum Mol Genet       Date:  2019-04-01       Impact factor: 6.150

Review 2.  A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges.

Authors:  Velmarini Vasquez; Joy Mitra; Haibo Wang; Pavana M Hegde; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2019-12-18       Impact factor: 11.685

3.  Live-Cell Assays for Cell Stress Responses Reveal New Patterns of Cell Signaling Caused by Mutations in Rhodopsin, α-Synuclein and TDP-43.

Authors:  Kevin M Harlen; Elizabeth C Roush; Joseph E Clayton; Scott Martinka; Thomas E Hughes
Journal:  Front Cell Neurosci       Date:  2019-12-18       Impact factor: 5.505

4.  Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhanced α-Synuclein Expression in Mice for Modeling Parkinson's Disease.

Authors:  Chung-Yin Lin; Ching-Yun Huang; Chiung-Mei Chen; Hao-Li Liu
Journal:  Pharmaceutics       Date:  2022-02-18       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.